Publications by authors named "SL Friedman"

Claim this Profile
R
Real-world Comparison of Steatosis-Associated Fibrosis Estimator and Fibrosis-4 Scores for Assessing Metabolic Dysfunction-associated Steatotic Liver Disease-related Fibrosis in a Highly Diverse Urban Metabolic Dysfunction-associated Steatotic Liver Disease Population.
Xiaotao Zhang, Vikram Sivakumar, Alejandra Paredes-Marin, Asher Leviton, Augusto Villanueva, Scott L Friedman

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis.
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, Giada Sebastiani, Jörn M Schattenberg, Scott L Friedman

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation.
Chittampalli N Yashaswini, Bogdan Mitran, Natalia Papadopoulos, Olivia Wegrzyniak, John Löfblom, Scott L Friedman

EJNMMI Radiopharm Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/Steatohepatitis.
Alejandra Paredes-Marin, Julia Napoli, Vikram Sivakumar, Christian Near, Helen Adams, Scott L Friedman

Dig Dis Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases.
Elmar Jaeckel, Scott L Friedman, Michael Hudecek, Ulrike Protzer

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging dimensions: a comparative analysis of 2D and 3D in vitro models for hepatocellular carcinoma research.
Leticia C Valente, Luana Riechelman-Casarin, Laura L P Esteves, Gabriel P Bacil, Tereza Cristina da Silva, Scott L Friedman

Arch Toxicol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosis.
Aina Anton, Sarah Shalaby, María Luisa Botero, Annabel Blasi, Yiliam Fundora, Scott L Friedman

Hepatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attention-Deficit/Hyperactivity Disorder in Medication Treated Preschool-Age Children Without and With Autism Spectrum Disorder: A Developmental-Behavioral Research Network Study.
Sandra L Friedman, Justine Shults, William Barbaresi, Ami Bax, Jaclyn Cacia

J Dev Behav Pediatr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACLY inhibition promotes tumour immunity and suppresses liver cancer.
Jaya Gautam, Jianhan Wu, James S V Lally, Jamie D McNicol, Russta Fayyazi, Scott L Friedman

Nature· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolvin D1-mediated cellular crosstalk protects against MASH.
Amaia Navarro-Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Scott L Friedman

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
Robert F Schwabe, Frank Tacke, Atsushi Sugimoto, Scott L Friedman

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases.
Raghavender Reddy Gopireddy, Dipankar Bhattacharya, Swastik Sen, Monica A Schwartz, Scott L Friedman

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis.
Andressa de Zawadzki, Diana J Leeming, Arun J Sanyal, Quentin M Anstee, Jörn M Schattenberg, Scott L Friedman

J Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective.
Zobair M Younossi, Homie Razavi, Michael Sherman, Alina M Allen, Quentin M Anstee, Scott L Friedman

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis.
Fanglin Ma, Miriam Longo, Marica Meroni, Dipankar Bhattacharya, Erika Paolini, Scott L Friedman

Cell Metab· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannose reduces fructose metabolism and reverses MASH in human liver slices and murine models in vivo.
John G Hong, Joshaya Trotman, Yvette Carbajal, Poulomi Dey, Mariel Glass, Scott L Friedman

Hepatol Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of tumor-reactive HSCs reveals their significance during different stages of liver metastasis.
Aitor Benedicto, Alba Herrero, Aritz Lopategi, Scott L Friedman, Maria Dolores Boyano

Hepatol Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fat, fibrosis, and the future: navigating the maze of MASLD/MASH.
Scott L Friedman

J Clin Invest· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we talk? The cryptic communications of hepatic stellate cells in lipid metabolism.
Scott L Friedman

Cell Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology.
Vlad Ratziu, Yusuf Yilmaz, Don Lazas, Scott L Friedman, Caroline Lackner

Hepatology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.
Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin, Tran To, Thomas Williamson, Scott L Friedman

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scholarship, not politics: Reply to Eidelson (2025).
Lenore E Walker, Ester Cole, Sarah L Friedman, Beth Rom-Rymer, Arlene Steinberg

Am Psychol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation.
Harrison T Muturi, Hilda E Ghadieh, Suman Asalla, Sumona G Lester, Getachew D Belew, Scott L Friedman

Mol Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells.
Kavita Prasad, Dipankar Bhattacharya, Shams Gamal Eldin Shams, Kimberly Izarraras, Tia Hart, Scott L Friedman

Cells· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swept up in the tsunami: Pediatric and adolescent steatotic (fatty) liver disease.
Scott L Friedman

Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis